• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中的心率变异性

Heart rate variability in heart failure.

作者信息

Musialik-Łydka Agata, Sredniawa Beata, Pasyk Stanisław

机构信息

Department of Cardiology, Silesian Medical Academy, Silesian Centre for Heart Diseases, Zabrze, Poland.

出版信息

Kardiol Pol. 2003 Jan;58(1):10-6.

PMID:14502297
Abstract

BACKGROUND

Heart rate variability (HRV) depicts the functional status of the autonomic nervous system and its effects on sinus node. Recently, HRV analysis has been introduced in patients with heart failure (CHF) to identify those who are at risk of cardiac death.

AIM

To analyse HRV in patients with CHF with depressed left ventricular ejection fraction (EF) and to relate HRV parameters to EF, NYHA functional class and other clinical parameters.

METHODS

The study group consisted of 105 patients with CHF (88 males, 17 females, mean age 54+/-12 years); 77 patients had ischaemic cardiomyopathy, and 28 - dilated cardiomyopathy. All patients were in NYHA class II-IV and had EF <40%. The mean value of echocardiographically assessed EF was 26.9+/-8.3%. The control group consisted of 30 gender- and age-matched healthy subjects. HRV analysis was performed in the time-domain from 24-hour Holter ECG.

RESULTS

All HRV variables were significantly lower in patients with CHF than in controls. Patients with NYHA class II had higher values of SDNN and SDANN than those in class III or IV. Patients with sustained or non-sustained ventricular tachycardia (VT) detected during Holter monitoring had lower SDNN and SDANN values than those without VT. Patients with diabetes had significantly lower SDNN and rMSSD values than the patients without diabetes. Similar results were found when patients with or without hypertension were compared. HRV parameters were similar in patients either with ischaemic or dilated cardiomyopathy. Also the values of EF were similar (27.4+/-8.4 vs 25.0+/-8.3%, respectively, NS). In the whole group of patients with CHF the values of SDNN and SDANN significantly correlated with EF (SDNN p<0.001, r=0.42; SDANN p<0.001, r=0.51). This correlation was stronger in the subset of patients with ischaemic cardiomyopathy (SDNN p=0.002. r=0.54; SDANN p=0.002; r=0.53) than in those with dilated cardiomyopathy (SDNN p=0.012, r=0.23; SDANN p=0.008, r=0.42). A significant negative correlation was found between all HRV parameters and NYHA class (SDNN p<0.001, r = -0.33; SDANN p<0.001, r = -0.38; rMSSD p<0.001, r = -0.13).

CONCLUSIONS

HRV is depressed in patients with CHF compared with healthy subjects. Among patients with CHF, HRV is further decreased in patients with more advanced NYHA class, lower EF and in those with diabetes, hypertension or VT on Holter monitoring.

摘要

背景

心率变异性(HRV)描述了自主神经系统的功能状态及其对窦房结的影响。最近,HRV分析已被引入心力衰竭(CHF)患者中,以识别有心脏死亡风险的患者。

目的

分析左心室射血分数(EF)降低的CHF患者的HRV,并将HRV参数与EF、纽约心脏协会(NYHA)功能分级及其他临床参数相关联。

方法

研究组由105例CHF患者组成(88例男性,17例女性,平均年龄54±12岁);77例患者患有缺血性心肌病,28例患有扩张型心肌病。所有患者均处于NYHA II-IV级,且EF<40%。经超声心动图评估的EF平均值为26.9±8.3%。对照组由30名年龄和性别匹配的健康受试者组成。通过24小时动态心电图在时域内进行HRV分析。

结果

CHF患者的所有HRV变量均显著低于对照组。NYHA II级患者的SDNN和SDANN值高于III级或IV级患者。在动态监测期间检测到持续性或非持续性室性心动过速(VT)的患者,其SDNN和SDANN值低于无VT的患者。糖尿病患者的SDNN和rMSSD值显著低于无糖尿病的患者。比较有或无高血压的患者时也发现了类似结果。缺血性或扩张型心肌病患者的HRV参数相似。EF值也相似(分别为27.4±8.4%和25.0±8.3%,无显著性差异)。在整个CHF患者组中,SDNN和SDANN值与EF显著相关(SDNN p<0.001,r=0.42;SDANN p<0.001,r=0.51)。这种相关性在缺血性心肌病患者亚组中比在扩张型心肌病患者中更强(SDNN p=0.002,r=0.54;SDANN p=0.002,r=0.53)(SDNN p=0.012,r=0.23;SDANN p=0.008,r=0.42)。在所有HRV参数与NYHA分级之间发现显著的负相关(SDNN p<0.001,r = -0.33;SDANN p<0.001,r = -0.38;rMSSD p<0.001,r = -0.13)。

结论

与健康受试者相比,CHF患者的HRV降低。在CHF患者中,NYHA分级更高、EF更低以及动态监测时有糖尿病、高血压或VT的患者,其HRV进一步降低。

相似文献

1
Heart rate variability in heart failure.心力衰竭中的心率变异性
Kardiol Pol. 2003 Jan;58(1):10-6.
2
Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.患有结构性心脏病且房室结传导能力下降患者的心率变异性。对心率变异性形成的见解。
Z Kardiol. 2004 Mar;93(3):229-33. doi: 10.1007/s00392-004-0050-z.
3
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.心率变异性降低作为缺血性或特发性扩张型心肌病所致慢性充血性心力衰竭患者死亡的独立预测因素。
Am J Cardiol. 1997 Jun 15;79(12):1645-50. doi: 10.1016/s0002-9149(97)00215-4.
4
[Changes in autonomic control of heart rate after ischemic cerebral stroke].[缺血性脑卒中后心率自主控制的变化]
Acta Med Croatica. 2003;57(4):269-73.
5
Cytokines and heart rate variability in patients with chronic heart failure.慢性心力衰竭患者的细胞因子与心率变异性
Kardiol Pol. 2005 Nov;63(5):478-85; discussion 486-7.
6
Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.奈西立肽(人B型利钠肽)与多巴酚丁胺对失代偿性心力衰竭患者心率变异性的影响
Am Heart J. 2004 Nov;148(5):e16. doi: 10.1016/j.ahj.2004.05.027.
7
[Study of heart rate variability in acute myocardial infarction and its relationship with ventricular function and other clinical variables].急性心肌梗死患者心率变异性及其与心室功能和其他临床变量关系的研究
Rev Esp Cardiol. 1996 Jan;49(1):29-34.
8
[The assessment and clinical significance of heart rate variability].[心率变异性的评估及临床意义]
Pol Merkur Lekarski. 1999 Dec;7(42):283-8.
9
Losartan improves heart rate variability and heart rate turbulence in heart failure due to ischemic cardiomyopathy.氯沙坦可改善缺血性心肌病所致心力衰竭患者的心率变异性和心率震荡。
J Card Fail. 2007 Dec;13(10):812-7. doi: 10.1016/j.cardfail.2007.08.002.
10
Heart rate variability in dilated cardiomyopathy.扩张型心肌病中的心率变异性
Indian Heart J. 2000 Mar-Apr;52(2):187-91.

引用本文的文献

1
Relationship between heart rate variability and echocardiography indices of cardiac function in healthy individuals.健康个体中心率变异性与心脏功能超声心动图指标之间的关系。
Clin Physiol Funct Imaging. 2025 Jan;45(1):e12910. doi: 10.1111/cpf.12910. Epub 2024 Nov 5.
2
Heart Rate Variability and Heart Failure with Reduced Ejection Fraction: A Systematic Review of Literature.心率变异性与射血分数降低的心力衰竭:文献系统评价
Curr Cardiol Rev. 2025;21(2):78-87. doi: 10.2174/011573403X327105241021180916.
3
Link between Yoga and Heart Rate Variability: Can Yoga Enhance the Cardiac Resonance.
瑜伽与心率变异性之间的联系:瑜伽能否增强心脏共鸣。
Int J Yoga. 2024 May-Aug;17(2):67-75. doi: 10.4103/ijoy.ijoy_50_24. Epub 2024 Sep 13.
4
Effect of urban environment on cardiovascular health: a feasibility pilot study using machine learning to predict heart rate variability in patients with heart failure.城市环境对心血管健康的影响:一项使用机器学习预测心力衰竭患者心率变异性的可行性初步研究。
Eur Heart J Digit Health. 2024 Jul 12;5(5):551-562. doi: 10.1093/ehjdh/ztae050. eCollection 2024 Sep.
5
Continuous long-term heart rate variability and risk assessment in pulmonary hypertension.肺动脉高压的连续长期心率变异性与风险评估。
Open Heart. 2023 Jun;10(1). doi: 10.1136/openhrt-2023-002302.
6
Exploring the use of Granger causality for the identification of chemical exposure based on physiological data.探索基于生理数据运用格兰杰因果关系来识别化学物质暴露情况。
Front Netw Physiol. 2023 Mar 15;3:1106650. doi: 10.3389/fnetp.2023.1106650. eCollection 2023.
7
A two-step pre-processing tool to remove Gaussian and ectopic noise for heart rate variability analysis.用于去除心率变异性分析中的高斯和异位噪声的两步预处理工具。
Sci Rep. 2022 Nov 1;12(1):18396. doi: 10.1038/s41598-022-21776-2.
8
Multimodal Assessment of the Pulse Rate Variability Analysis Module of a Photoplethysmography-Based Telemedicine System.基于光电容积脉搏波的远程医疗系统的脉搏率变异性分析模块的多模态评估。
Sensors (Basel). 2021 Aug 18;21(16):5544. doi: 10.3390/s21165544.
9
The effects of clinical and angiographic aspects of coronary artery disease on the cardiac autonomic function: a single-center prospective cohort study.冠状动脉疾病的临床和血管造影方面对心脏自主神经功能的影响:一项单中心前瞻性队列研究。
Am J Cardiovasc Dis. 2021 Jun 15;11(3):410-420. eCollection 2021.
10
Usefulness of heart rhythm complexity in heart failure detection and diagnosis.心率复杂度在心衰检测和诊断中的应用。
Sci Rep. 2020 Sep 10;10(1):14916. doi: 10.1038/s41598-020-71909-8.